University of Birmingham study identifies P2X7 receptor as target for brain inflammation

Researchers at the University of Birmingham have identified the P2X7 receptor as a key driver of neuroinflammation, offering a potential new target for treating various neurological and psychiatric conditions. The study, published in the journal Brain and led by Professor Nicholas Barnes, utilized human brain cell cultures and tissue samples obtained during neurosurgery to observe the receptor's role.

Findings indicate that the P2X7 receptor triggers the release of cytokines, which are proteins that regulate inflammatory responses in the nervous system. By using a specific antagonist to block this receptor, the team successfully reduced inflammatory signals in both laboratory cell models and human brain tissue fragments.

The discovery suggests possibilities for repurposing existing therapeutics to combat inflammation at its source. This approach could have implications for managing a wide spectrum of disorders, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, traumatic brain injury (TBI), and inflammation-linked psychiatric conditions such as depression, psychosis, and schizophrenia.